Want to join the conversation?
Cruise ship operator $CCL posted higher 2Q16 earnings, including unrealized gains on fuel derivatives, of $605MM, or $0.80 per diluted EPS vs. $222MM, or $0.29 diluted EPS for 2Q15. Adjusted diluted EPS was $0.49 for the quarter. Revenues rose 2.8% to $3.7Bil vs. 2Q15, helped by higher passenger ticket and onboard and other revenues.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.